Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Shenzhou Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in steroid hormone APIs and their intermediates. Founded in 1989 and headquartered in Linhai, Zhejiang, the company has established itself as a key global supplier of corticosteroids such as dexamethasone, betamethasone, and prednisolone. The company operates state-of-the-art manufacturing facilities that comply with international GMP standards, serving clients across the pharmaceutical and healthcare sectors worldwide. Their product portfolio is primarily utilized in the formulation of medications for inflammatory diseases, autoimmune disorders, and respiratory conditions. Shenzhou Pharmaceutical is recognized for its strong R&D capabilities in the synthesis and fermentation of complex steroid structures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Shenzhou Pharmaceutical.